VOTE TODAY The Avid Board of Directors Unanimously Recommends that Avid Stockholders Vote “FOR” the proposed transaction with GHO and Ampersand. Vote TODAY online, by telephone or by signing ...

On 7 November 2024, GHO and Ampersand entered into a definitive merger agreement for Avid to be acquired by funds managed by GHO and Ampersand in an all-cash transaction valued at approximately $1 ...

Ampersand’s Series B funding will fuel the continued development of its computationally powered Address, Navigate, Determine (AND)™ Platform to program AND-Body™ Therapeutics, a new category ...

Acquisition amplifies Ampersand’s in-house capabilities to generate AND-Body™ Therapeutics - programmed biologics across a broad range of diseasesBOSTON, Jan. 03, 2024 (GLOBE NEWSWIRE ...